Baxter Healthcare - Articles and news items

Baxter BioScience acquires Oncaspar portfolio for leukaemia for $900m

Industry news / 13 May 2015 / Victoria White

Baxter has signed a definitive agreement to acquire the Oncaspar (pegaspargase) product portfolio from Sigma-Tau for US $900 million…

Sigma Aldrich

SAFC and Baxter BioPharma Solutions collaborate on complete ADC offering

Industry news / 24 September 2014 / Sigma-Aldrich

Sigma-Aldrich Corporation’s SAFC® Commercial custom manufacturing services business unit, and Baxter’s BioPharma Solutions business have established a collaborative manufacturing agreement…

Baxter logo on office building

Baxter announces plans to create two separate global healthcare companies

Industry news, News / 28 March 2014 / Baxter International Inc.

Baxter International Inc. has announced plans to create two separate, independent global healthcare companies – one focused on developing and marketing innovative biopharmaceuticals and the other on life-saving medical products…

Baxter logo on office building

Baxter achieves its first quarter expectations

Industry news, News / 19 April 2013 / Baxter International Inc.

Baxter has reported first quarter financial results in line with the company’s previously issued guidance…

Manufacturing & Packaging Supplement 2013

Pharmaceutical Manufacturing & Packaging: In-depth focus 2013

Issue 1 2013, Manufacturing & Packaging, Supplements / 18 February 2013 / Dennis Jenke

The chemical safety assessment process for extractables and leachables associated with packaged pharmaceutical products.
INTERPHEX 2013: Show preview

Achieving Quality & Process Excellence in the Pharma Industry

Industry news, News / 11 May 2011 / Fleming Europe

Network with c-level industry leaders from AstraZeneca, Sanofi Aventis, Roche, Novartis, Baxter, Pfizer & Abbott…

Novel and emerging sterilisation technologies

Issue 5 2009, Past issues / 9 October 2009 /

The increasing number and diversity of traditional patient therapies, medical devices, and combinatorial products has created an increasing world-wide interest in the innovation of novel sterilisation technologies. In contrast to traditional moist heat sterilisation processes, emerging technologies are diverse, predominantly reliant on physical processes, involve multiple mechanisms of microbial inactivation and span the complete electromagnetic spectrum. New and emerging technologies include high hydrostatic pressures, pulsed electric fields and low-temperature plasmas that accomplish expedient inactivation of microorganisms at ambient or moderately elevated temperatures. This review presents a high level overview of novel, emerging and developing sterilisation technologies with particular focus upon two potential winners in the race to novel, non-traditional commercially viable modes of sterilisation.


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...